allele_iedb stringclasses 37
values | allele stringclasses 37
values | peptide stringlengths 7 15 | peptide_length int64 7 15 | measurement_type stringclasses 2
values | measurement_value float64 0 14.3M | measurement_units stringclasses 1
value | assay_method stringclasses 6
values | assay_response stringclasses 2
values | pubmed_id float64 7.51M 37.8M ⌀ | parent_protein stringlengths 3 188 ⌀ | protein_accession stringlengths 6 14 | source_organism stringclasses 849
values | assay_pdb_id float64 | flagged bool 2
classes | has_structures bool 1
class | num_pdbs int64 22 25 | rosetta_best_score float64 -633.25 1.04 | rosetta_mean_score float64 -620.04 44 | pdb_dir stringlengths 24 32 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLA-B_35_03 | B*35:03 | HPNIEEVAL | 9 | IC50 | 6.8 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 22,508,927 | Genome polyprotein | ACE82359.1 | hepatitis C virus genotype 1a | null | false | true | 25 | -585.842 | -565.7758 | structures/B3503/HPNIEEVAL |
HLA-B_35_03 | B*35:03 | SPGDLQTLAL | 10 | IC50 | 16,115 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 22,539,795 | Insulin-1 | NP_032412.3 | Mus musculus | null | false | true | 25 | -568.58 | -529.3615 | structures/B3503/SPGDLQTLAL |
HLA-B_42_01 | B*42:01 | SPGDLQTLAL | 10 | IC50 | 35 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 22,539,795 | Insulin-1 | NP_032412.3 | Mus musculus | null | false | true | 25 | -575.301 | -549.8056 | structures/B4201/SPGDLQTLAL |
HLA-B_42_01 | B*42:01 | GPGAGSLQPLAL | 12 | IC50 | 6,066 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 22,539,795 | Insulin | P01308.1 | Homo sapiens | null | false | true | 25 | -580.154 | -529.118 | structures/B4201/GPGAGSLQPLAL |
HLA-B_13_02 | B*13:02 | ELPKYGVKV | 9 | Kd | 10,000 | nM | purified MHC/direct/fluorescence | dissociation constant (KD) | 34,290,406 | Large ribosomal subunit protein uL18 | A0A2R8Y4A2.1 | Homo sapiens | null | false | true | 25 | -569.14 | -529.8654 | structures/B1302/ELPKYGVKV |
HLA-B_45_01 | B*45:01 | SENERGYYI | 9 | IC50 | 336 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Liver stage antigen 1 | Q25893.1 | Plasmodium falciparum | null | false | true | 25 | -563.413 | -541.4912 | structures/B4501/SENERGYYI |
HLA-B_45_01 | B*45:01 | RENANQLVV | 9 | IC50 | 37 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Thrombospondin-related anonymous protein | AAG12328.1 | Plasmodium falciparum | null | false | true | 25 | -594.309 | -558.9796 | structures/B4501/RENANQLVV |
HLA-B_45_01 | B*45:01 | NELNYDNAGI | 10 | IC50 | 457 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Circumsporozoite protein | AAA29547.1 | Plasmodium falciparum | null | false | true | 25 | -579.154 | -542.0438 | structures/B4501/NELNYDNAGI |
HLA-B_45_01 | B*45:01 | AELLAACF | 8 | IC50 | 247 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Protein P | AAP79852.1 | Hepatitis B virus | null | false | true | 25 | -565.646 | -542.5842 | structures/B4501/AELLAACF |
HLA-B_45_01 | B*45:01 | AELLAACFA | 9 | IC50 | 6.6 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Protein P | AAP79852.1 | Hepatitis B virus | null | false | true | 25 | -587.657 | -555.0832 | structures/B4501/AELLAACFA |
HLA-B_45_01 | B*45:01 | RETVLEYLV | 9 | IC50 | 205 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Capsid protein | AAO62974.1 | Hepatitis B virus | null | false | true | 25 | -570.839 | -500.478 | structures/B4501/RETVLEYLV |
HLA-B_45_01 | B*45:01 | AEAALENLV | 9 | IC50 | 35 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Genome polyprotein | Q81495.3 | Hepatitis C virus (isolate HCV-K3a/650) | null | false | true | 25 | -575.513 | -565.832 | structures/B4501/AEAALENLV |
HLA-B_45_01 | B*45:01 | AENLYVTVF | 9 | IC50 | 69 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | null | ONTIE_0002602 | Human immunodeficiency virus 1 | null | false | true | 25 | -578.537 | -534.1985 | structures/B4501/AENLYVTVF |
HLA-B_45_01 | B*45:01 | AENLWVTVYY | 10 | IC50 | 245 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Envelope glycoprotein gp160 | AAA80623.1 | Human immunodeficiency virus 1 | null | false | true | 25 | -591.664 | -552.8358 | structures/B4501/AENLWVTVYY |
HLA-B_45_01 | B*45:01 | AENLWVTVY | 9 | IC50 | 68 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Envelope glycoprotein gp160 | AAA80623.1 | Human immunodeficiency virus 1 | null | false | true | 25 | -559.054 | -533.8975 | structures/B4501/AENLWVTVY |
HLA-B_45_01 | B*45:01 | ADKNLIKCS | 9 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | RING finger protein Z | AAQ55253.1 | Mammarenavirus guanaritoense | null | false | true | 25 | -574.735 | -543.7753 | structures/B4501/ADKNLIKCS |
HLA-B_45_01 | B*45:01 | FEFTSFFY | 8 | IC50 | 12,811 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | P03431.1 | Influenza A virus | null | false | true | 25 | -575.586 | -541.3988 | structures/B4501/FEFTSFFY |
HLA-B_45_01 | B*45:01 | FESKSMKL | 8 | IC50 | 53,678 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | P03431.1 | Influenza A virus | null | false | true | 25 | -587.097 | -561.1407 | structures/B4501/FESKSMKL |
HLA-B_45_01 | B*45:01 | AEIMKICST | 9 | IC50 | 139 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | AAA43637.1 | Influenza A virus | null | false | true | 25 | -588.379 | -575.9348 | structures/B4501/AEIMKICST |
HLA-B_45_01 | B*45:01 | AESRKLLLI | 9 | IC50 | 167 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | Polymerase acidic protein | NP_775531.1 | Influenza A virus | null | false | true | 25 | -564.908 | -537.6573 | structures/B4501/AESRKLLLI |
HLA-B_45_01 | B*45:01 | CEKLEQSGL | 9 | IC50 | 359 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | P03431.1 | Influenza A virus | null | false | true | 25 | -582.221 | -533.7259 | structures/B4501/CEKLEQSGL |
HLA-B_45_01 | B*45:01 | CELTDSSWI | 9 | IC50 | 139 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | Polymerase acidic protein | NP_775531.1 | Influenza A virus | null | false | true | 25 | -580.18 | -542.6047 | structures/B4501/CELTDSSWI |
HLA-B_45_01 | B*45:01 | AEIEDLIFLA | 10 | IC50 | 8.9 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | Nucleoprotein | AAK18005.1 | Influenza A virus | null | false | true | 25 | -569.83 | -540.2655 | structures/B4501/AEIEDLIFLA |
HLA-B_45_01 | B*45:01 | YERMCNILKG | 10 | IC50 | 19,823 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | Nucleoprotein | AAK18005.1 | Influenza A virus | null | false | true | 25 | -558.623 | -510.3544 | structures/B4501/YERMCNILKG |
HLA-B_45_01 | B*45:01 | AEKPKFLPDLY | 11 | IC50 | 2,929 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | Polymerase acidic protein | NP_775531.1 | Influenza A virus | null | false | true | 25 | -564.406 | -515.7918 | structures/B4501/AEKPKFLPDLY |
HLA-B_37_01 | B*37:01 | RQSSGSSSSGF | 11 | IC50 | 316.8 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | ATP-dependent RNA helicase DDX3Y | NP_004651.2 | Homo sapiens | null | false | true | 25 | -586.431 | -539.7983 | structures/B3701/RQSSGSSSSGF |
HLA-B_37_01 | B*37:01 | FQILHDRFF | 9 | IC50 | 365.3 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | null | false | true | 25 | -585.791 | -514.5398 | structures/B3701/FQILHDRFF |
HLA-B_37_01 | B*37:01 | TEAEKWPFF | 9 | IC50 | 394.2 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Sex-determining region Y protein (Fragment) | ACQ77096.1 | Tarsius lariang | null | false | true | 25 | -566.552 | -486.8687 | structures/B3701/TEAEKWPFF |
HLA-B_37_01 | B*37:01 | KVADVDLAVPV | 11 | IC50 | 906.6 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Gamma-taxilin | NP_115965.1 | Homo sapiens | null | false | true | 25 | -589.808 | -532.2005 | structures/B3701/KVADVDLAVPV |
HLA-B_37_01 | B*37:01 | IVDCLTEMYY | 10 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | null | false | true | 25 | -566.793 | -523.2168 | structures/B3701/IVDCLTEMYY |
HLA-B_37_01 | B*37:01 | ILNRETLLDFV | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Putative gamma-taxilin 2 | AAK13476.1 | Homo sapiens | null | false | true | 25 | -572.504 | -516.4488 | structures/B3701/ILNRETLLDFV |
HLA-B_37_01 | B*37:01 | FLLPILSQIYT | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | RNA helicase | XP_001378186.1 | Monodelphis domestica | null | false | true | 25 | -569.601 | -459.0111 | structures/B3701/FLLPILSQIYT |
HLA-B_37_01 | B*37:01 | SLMASSPTSI | 10 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Lysine-specific demethylase 5D | AAC50806.1 | Homo sapiens | null | false | true | 25 | -582.304 | -545.1512 | structures/B3701/SLMASSPTSI |
HLA-B_37_01 | B*37:01 | SLLERGQQLGV | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | [histone H3]-trimethyl-L-lysine(4) demethylase | XP_001064297.1 | Rattus norvegicus | null | false | true | 25 | -549.714 | -497.0372 | structures/B3701/SLLERGQQLGV |
HLA-B_37_01 | B*37:01 | MIKYCLLKILK | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Histone demethylase UTY | NP_033510.2 | Mus musculus | null | false | true | 25 | -581.791 | -539.7794 | structures/B3701/MIKYCLLKILK |
HLA-B_37_01 | B*37:01 | GSSDFQVHFLK | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | null | false | true | 25 | -556.552 | -532.7305 | structures/B3701/GSSDFQVHFLK |
HLA-B_37_01 | B*37:01 | YSLEYFQFVKK | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | ubiquitinyl hydrolase 1 | XP_001366553.1 | Monodelphis domestica | null | false | true | 25 | -563.228 | -483.1645 | structures/B3701/YSLEYFQFVKK |
HLA-B_37_01 | B*37:01 | KSLTTTMQFK | 10 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Protocadherin-11 Y-linked | NP_116753.1 | Homo sapiens | null | false | true | 25 | -581.743 | -487.2569 | structures/B3701/KSLTTTMQFK |
HLA-B_37_01 | B*37:01 | SYMMDDLELI | 10 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | null | false | true | 25 | -545.016 | -493.8796 | structures/B3701/SYMMDDLELI |
HLA-B_37_01 | B*37:01 | YFYYNAFHWAI | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Histone demethylase UTY | AAY16579.1 | Homo sapiens | null | false | true | 25 | -581.115 | -486.819 | structures/B3701/YFYYNAFHWAI |
HLA-B_37_01 | B*37:01 | RYSHWTKL | 8 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Sex-determining region Y protein | P48046.1 | Gorilla gorilla gorilla | null | false | true | 25 | -576.454 | -553.7766 | structures/B3701/RYSHWTKL |
HLA-B_37_01 | B*37:01 | SSKMFNYFK | 9 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Isoform 4 of Neuroligin-4, Y-linked | AAH32567.1 | Homo sapiens | null | false | true | 25 | -592.726 | -570.5129 | structures/B3701/SSKMFNYFK |
HLA-B_37_01 | B*37:01 | RMILPMSRAFR | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | NP_683745.2 | Mus musculus | null | false | true | 25 | -588.983 | -552.6933 | structures/B3701/RMILPMSRAFR |
HLA-B_37_01 | B*37:01 | ELFARSSDPR | 10 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | null | false | true | 25 | -580.406 | -557.7733 | structures/B3701/ELFARSSDPR |
HLA-B_37_01 | B*37:01 | LVTMGTGTFGR | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Putative serine/threonine-protein kinase PRKY | O43930.1 | Homo sapiens | null | false | true | 25 | -548.624 | -522.7722 | structures/B3701/LVTMGTGTFGR |
HLA-B_37_01 | B*37:01 | LPADPASVL | 9 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Sex-determining region Y protein (Fragment) | ABM65922.1 | Ateles geoffroyi | null | false | true | 25 | -594.867 | -574.0286 | structures/B3701/LPADPASVL |
HLA-B_37_01 | B*37:01 | MVRVLTVIKEY | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | CAA73940.1 | Homo sapiens | null | false | true | 25 | -545.741 | -506.3387 | structures/B3701/MVRVLTVIKEY |
HLA-B_37_01 | B*37:01 | YQSMIRPPY | 9 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Amelogenin, Y isoform (Fragment) | XP_001145496.1 | Pan troglodytes | null | false | true | 25 | -561.749 | -525.1817 | structures/B3701/YQSMIRPPY |
HLA-B_37_01 | B*37:01 | VALFSSCPVAY | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9X | NP_033507.2 | Mus musculus | null | false | true | 25 | -560.655 | -532.5462 | structures/B3701/VALFSSCPVAY |
HLA-B_37_01 | B*37:01 | FPHTELANL | 9 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | null | false | true | 25 | -579.509 | -486.606 | structures/B3701/FPHTELANL |
HLA-B_37_01 | B*37:01 | LPSCPTNFCIF | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Isoform 2 of Histone demethylase UTY | BAF85547.1 | Homo sapiens | null | false | true | 25 | -572.898 | -488.4655 | structures/B3701/LPSCPTNFCIF |
HLA-B_37_01 | B*37:01 | RPPYSSYGY | 9 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Amelogenin, Y isoform (Fragment) | XP_001145496.1 | Pan troglodytes | null | false | true | 25 | -578.224 | -500.9122 | structures/B3701/RPPYSSYGY |
HLA-B_37_01 | B*37:01 | TFVPIAWAAAY | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Zinc finger protein Y-linked | ACL51661.1 | Callithrix jacchus | null | false | true | 25 | -556.955 | -490.3761 | structures/B3701/TFVPIAWAAAY |
HLA-B_37_01 | B*37:01 | LEYFQFVKKLL | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | ubiquitinyl hydrolase 1 | XP_001366553.1 | Monodelphis domestica | null | false | true | 25 | -539.473 | -494.0599 | structures/B3701/LEYFQFVKKLL |
HLA-B_37_01 | B*37:01 | YPDPVIKV | 8 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Small ribosomal subunit protein eS4, Y isoform 1 | EAX02770.1 | Homo sapiens | null | false | true | 25 | -606.838 | -577.7053 | structures/B3701/YPDPVIKV |
HLA-B_52_01 | B*52:01 | QGFPWDILF | 9 | IC50 | 18 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | AAG26087.1 | Hepatitis delta virus | null | false | true | 25 | -548.735 | -509.6325 | structures/B5201/QGFPWDILF |
HLA-B_52_01 | B*52:01 | DRGFPWDILF | 10 | IC50 | 4,682 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | AVV65245.1 | Hepatitis delta virus | null | false | true | 25 | -547.616 | -503.2128 | structures/B5201/DRGFPWDILF |
HLA-B_52_01 | B*52:01 | NQGIPWDILF | 10 | IC50 | 1,469 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | ONTIE_0003412 | Hepatitis delta virus | null | false | true | 25 | -552.953 | -497.4428 | structures/B5201/NQGIPWDILF |
HLA-B_52_01 | B*52:01 | QGFPWDMLF | 9 | IC50 | 90 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | AAF13849.1 | Hepatitis delta virus | null | false | true | 25 | -565.182 | -532.5892 | structures/B5201/QGFPWDMLF |
HLA-B_52_01 | B*52:01 | RGFPWDILF | 9 | IC50 | 224 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | AVV65245.1 | Hepatitis delta virus | null | false | true | 25 | -577.686 | -542.4519 | structures/B5201/RGFPWDILF |
HLA-B_52_01 | B*52:01 | QGFPWDLLF | 9 | IC50 | 135 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | AAO49188.1 | Hepatitis delta virus | null | false | true | 25 | -557.888 | -513.7281 | structures/B5201/QGFPWDLLF |
HLA-B_52_01 | B*52:01 | SQGFPWDILF | 10 | IC50 | 3,657 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | P25989.1 | Hepatitis delta virus | null | false | true | 25 | -546.067 | -498.1719 | structures/B5201/SQGFPWDILF |
HLA-B_14_02 | B*14:02 | MVFGRFSFA | 9 | Kd | 1,178 | nM | purified MHC/direct/fluorescence | dissociation constant (KD) | null | Membrane protein, putative | AAU48420.1 | Burkholderia mallei ATCC 23344 | null | false | true | 25 | -566.687 | -541.4444 | structures/B1402/MVFGRFSFA |
HLA-B_14_02 | B*14:02 | FRKAQIQGL | 9 | Kd | 3,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Epstein-Barr nuclear antigen 6 | S33015 | human gammaherpesvirus 4 | null | false | true | 25 | -556.98 | -532.4776 | structures/B1402/FRKAQIQGL |
HLA-B_14_02 | B*14:02 | TGIAIIAYI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Lmo2486 protein | CAD00564.1 | Listeria monocytogenes EGD-e | null | false | true | 25 | -561.762 | -554.55 | structures/B1402/TGIAIIAYI |
HLA-B_14_02 | B*14:02 | YLDNVGVHI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Phosphoprotein | AAK55078.1 | Lyssavirus rabies | null | false | true | 25 | -593.277 | -532.3088 | structures/B1402/YLDNVGVHI |
HLA-B_14_02 | B*14:02 | TRAPAPFPL | 9 | Kd | 565 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | DNA polymerase III subunit epsilon | AAL59738.1 | Vibrio cholerae | null | false | true | 25 | -586.426 | -542.3101 | structures/B1402/TRAPAPFPL |
HLA-B_14_02 | B*14:02 | TTRAVNMEV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Gluconate 2-dehydrogenase | AAL53555.1 | Brucella melitensis bv. 1 str. 16M | null | false | true | 25 | -559.67 | -539.5118 | structures/B1402/TTRAVNMEV |
HLA-B_14_02 | B*14:02 | KQIVIINPM | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | GlcNAc phosphomutase | AAO10081.1 | Vibrio vulnificus CMCP6 | null | false | true | 25 | -590.347 | -576.5902 | structures/B1402/KQIVIINPM |
HLA-B_14_02 | B*14:02 | MYPFIFFIV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Hypothetical membrane spanning protein | AAO90371.1 | Coxiella burnetii RSA 493 | null | false | true | 25 | -577.271 | -510.7029 | structures/B1402/MYPFIFFIV |
HLA-B_14_02 | B*14:02 | WAIQCYTGV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Na+/H+ antiporter NhaC | AAO07968.1 | Vibrio vulnificus CMCP6 | null | false | true | 25 | -566.022 | -530.0554 | structures/B1402/WAIQCYTGV |
HLA-B_14_02 | B*14:02 | ELAPIRVNA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Dehydrogenases with different specificities | BAC97625.1 | Vibrio vulnificus YJ016 | null | false | true | 25 | -592.077 | -507.6166 | structures/B1402/ELAPIRVNA |
HLA-B_14_02 | B*14:02 | FTWQHNYYL | 9 | Kd | 20,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | 40S ribosomal protein S10 | EAK87991.1 | Cryptosporidium parvum Iowa II | null | false | true | 25 | -585.847 | -542.8509 | structures/B1402/FTWQHNYYL |
HLA-B_14_02 | B*14:02 | NGNFNFERV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Glucosidase II subunit alpha | EAK89133.1 | Cryptosporidium parvum Iowa II | null | false | true | 25 | -550.607 | -524.9519 | structures/B1402/NGNFNFERV |
HLA-B_14_02 | B*14:02 | SVFELSNFA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | null | BAC93293.1 | Vibrio vulnificus YJ016 | null | false | true | 25 | -567.053 | -502.4737 | structures/B1402/SVFELSNFA |
HLA-B_14_02 | B*14:02 | TVFRNQNRV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Shares a domain with a conserved HREF motif with the CWF15 protein that is involved in mRNA splicing | EAK89397.1 | Cryptosporidium parvum Iowa II | null | false | true | 25 | -572.836 | -367.5504 | structures/B1402/TVFRNQNRV |
HLA-B_14_02 | B*14:02 | ERAFQNWSV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | DNA topoisomerase | EAL47247.1 | Entamoeba histolytica HM-1:IMSS | null | false | true | 25 | -577.903 | -513.3426 | structures/B1402/ERAFQNWSV |
HLA-B_14_02 | B*14:02 | FTLINWRSV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | tRNA pseudouridine synthase, putative | EAL50898.1 | Entamoeba histolytica HM-1:IMSS | null | false | true | 25 | -585.182 | -550.2807 | structures/B1402/FTLINWRSV |
HLA-B_14_02 | B*14:02 | IESNPLFPV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Dedicator of cytokinesis protein | EAL49146.1 | Entamoeba histolytica HM-1:IMSS | null | false | true | 25 | -581.624 | -549.9445 | structures/B1402/IESNPLFPV |
HLA-B_14_02 | B*14:02 | NPAACSYMV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | EAL50926.1 | Entamoeba histolytica HM-1:IMSS | null | false | true | 25 | -572.187 | -437.9042 | structures/B1402/NPAACSYMV |
HLA-B_14_02 | B*14:02 | EGAGIDDPV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | AcrB/AcrD/AcrF family protein | EAL56425.1 | Campylobacter coli RM2228 | null | false | true | 25 | -578.348 | -551.3372 | structures/B1402/EGAGIDDPV |
HLA-B_14_02 | B*14:02 | FFSPFFFSL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Clustered-asparagine-rich protein | CAJ20722.1 | Toxoplasma gondii RH | null | false | true | 25 | -569.981 | -487.2329 | structures/B1402/FFSPFFFSL |
HLA-B_14_02 | B*14:02 | FMVYVPLPA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Isocitrate dehydrogenase kinase/phosphatase | ABG16349.1 | Yersinia pestis Nepal516 | null | false | true | 25 | -587.954 | -575.4614 | structures/B1402/FMVYVPLPA |
HLA-B_14_02 | B*14:02 | YQAENSTAE | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Protein bdm | ABG69490.1 | Escherichia coli 536 | null | false | true | 25 | -581.016 | -498.8863 | structures/B1402/YQAENSTAE |
HLA-B_14_02 | B*14:02 | FGALFMWLL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Cytochrome oxidase subunit | ABF04835.1 | Shigella flexneri 5 str. 8401 | null | false | true | 25 | -584.931 | -567.9209 | structures/B1402/FGALFMWLL |
HLA-B_14_02 | B*14:02 | KQIGGTLFE | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Glutamate 5-kinase | CAL34268.1 | Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 | null | false | true | 25 | -573.427 | -473.6706 | structures/B1402/KQIGGTLFE |
HLA-B_14_02 | B*14:02 | QQRPDLILV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Endonuclease V | CAL22320.1 | Yersinia pestis CO92 | null | false | true | 25 | -543.51 | -471.85 | structures/B1402/QQRPDLILV |
HLA-B_14_02 | B*14:02 | GVDGGWQAL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase | ABM49996.1 | Burkholderia mallei SAVP1 | null | false | true | 25 | -569.032 | -530.2502 | structures/B1402/GVDGGWQAL |
HLA-B_14_02 | B*14:02 | MGMEQTMSV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | MSHA biogenesis protein MshN | EAX58236.1 | Vibrio cholerae 2740-80 | null | false | true | 25 | -570.395 | -536.4926 | structures/B1402/MGMEQTMSV |
HLA-B_14_02 | B*14:02 | NVMDPMHGA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Iron-sulfur cluster-binding protein, rieske family | ABM49342.1 | Burkholderia mallei SAVP1 | null | false | true | 25 | -600.678 | -556.512 | structures/B1402/NVMDPMHGA |
HLA-B_14_02 | B*14:02 | RVACRDVEV | 9 | Kd | 3,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Putative cytochrome P450 140 | CAL71904.1 | Mycobacterium tuberculosis variant bovis BCG str. Pasteur 1173P2 | null | false | true | 25 | -577.677 | -528.1645 | structures/B1402/RVACRDVEV |
HLA-B_14_02 | B*14:02 | EGFDPRALI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Glycerophosphoryl diester phosphodiesterase family protein | ABQ60400.1 | Brucella ovis ATCC 25840 | null | false | true | 25 | -562.366 | -481.7314 | structures/B1402/EGFDPRALI |
HLA-B_14_02 | B*14:02 | HQFTSNPEV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | FHA domain-containing protein | EDM60245.1 | Vibrio parahaemolyticus AQ3810 | null | false | true | 25 | -598.857 | -546.5586 | structures/B1402/HQFTSNPEV |
HLA-B_14_02 | B*14:02 | MTACGRIVV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | TfuA-like core domain-containing protein | EBA41824.1 | Mycobacterium tuberculosis str. Haarlem | null | false | true | 25 | -574.499 | -513.5247 | structures/B1402/MTACGRIVV |
HLA-B_14_02 | B*14:02 | EDFEIFYNL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Ribonuclease D | ABV79247.1 | Rickettsia bellii OSU 85-389 | null | false | true | 25 | -590.307 | -547.1164 | structures/B1402/EDFEIFYNL |
HLA-B_14_02 | B*14:02 | ETVWPFFYA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Nitrate reductase | ABX61793.1 | Brucella canis ATCC 23365 | null | false | true | 25 | -567.653 | -544.3466 | structures/B1402/ETVWPFFYA |
HLA-B_14_02 | B*14:02 | FTARIIIFS | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | ABV75419.1 | Rickettsia akari str. Hartford | null | false | true | 25 | -575.874 | -493.3533 | structures/B1402/FTARIIIFS |
HLA-B_14_02 | B*14:02 | FVMPIFEQI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Prophage LambdaBa01, membrane protein | EDR16741.1 | Bacillus anthracis str. A0488 | null | false | true | 25 | -583.321 | -560.9087 | structures/B1402/FVMPIFEQI |
HLA-B_14_02 | B*14:02 | MTFPLHFRS | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | EDO77069.1 | Giardia lamblia ATCC 50803 | null | false | true | 25 | -595.791 | -562.9997 | structures/B1402/MTFPLHFRS |
HLA-B_14_02 | B*14:02 | MTYLDGHPV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | EDO78551.1 | Giardia lamblia ATCC 50803 | null | false | true | 25 | -599.185 | -572.5628 | structures/B1402/MTYLDGHPV |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.